The bill would also transfer control of the state’s prescription monitoring system, KASPER, to the attorney general’s office and require any physicians prescribing schedule II and III narcotics to use the database.
The Kentucky Medical Association opposes certain parts of the bill, including a proposed $50 yearly fee for prescribers and the “broad and overarching authority” over KASPER given to the attorney general. “We think there are some legitimate, very basic concerns in this bill,” said KMA lobbyist Bill Doll.
Related Articles on Pain Management:
The Digital Doctor: How to Harness the Internet’s Power to Enhance Patient Relationships and Practice Revenue
NeuroMetrix Seeks FDA Approval for New Pain Therapy Device
Physician Editorial: Pain Clinics Should Be Source of Comfort, Not Pills
